Agarwal Arjun sold ORKA
October 12, 2026 · Form 4 insider transaction
Agarwal Arjun sold 200 shares of Oruka Therapeutics, Inc. at $82.83 per share, a transaction worth $16.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
200
Price
$82.83
Total value
$16.6K
InsiderAgarwal Arjun
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 12, 2026
Filing dateOctober 13, 2026
Shares owned after14,219
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.76 to $82.91, inclusive.